CD8A and neoplasm: Extensive immune monitoring demonstrated that the majority of patients exhibited evidence of increased peripheral blood CD4+ and CD8+ T-cell activation and proliferation, with a subset of patients showing the expansion of CD103+ CD39+ CD8+ TIL, which are enriched for tumor-reactivity, and correlate with greater disease-free survival.